AFP and cancer: utilized VirScan to detect a viral exposure signal that was associated with hepatocellular carcinoma and used it prospectively in at-risk patients to identify patients who were going to develop cancer, and their viral exposure signal biomarker was superior to that of the alpha-fetoprotein test (107).